Terms: = Colorectal cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Treatment
61 results:
1. Preclinical Repurposing of Sitagliptin as a Drug Candidate for colorectal cancer by Targeting
Shih JW; Wu ATH; Mokgautsi N; Wei PL; Huang YJ
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203779
[TBL] [Abstract] [Full Text] [Related]
2. Elucidation of the anti-colon cancer mechanism of Phellinus baumii polyphenol by an integrative approach of network pharmacology and experimental verification.
Liu X; Cui S; Li W; Xie H; Shi L
Int J Biol Macromol; 2023 Dec; 253(Pt 6):127429. PubMed ID: 37838121
[TBL] [Abstract] [Full Text] [Related]
3. Association of Age With treatment-Related Adverse Events and Survival in Patients With Metastatic colorectal cancer.
Meng L; Thapa R; Delgado MG; Gomez MF; Ji R; Knepper TC; Hubbard JM; Wang X; Permuth JB; Kim RD; Laber DA; Xie H
JAMA Netw Open; 2023 Jun; 6(6):e2320035. PubMed ID: 37358854
[TBL] [Abstract] [Full Text] [Related]
4. A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF
Ruiz-Saenz A; Atreya CE; Wang C; Pan B; Dreyer CA; Brunen D; Prahallad A; Muñoz DP; Ramms DJ; Burghi V; Spassov DS; Fewings E; Hwang YC; Cowdrey C; Moelders C; Schwarzer C; Wolf DM; Hann B; VandenBerg SR; Shokat K; Moasser MM; Bernards R; Gutkind JS; van 't Veer LJ; Coppé JP
Nat Cancer; 2023 Feb; 4(2):240-256. PubMed ID: 36759733
[TBL] [Abstract] [Full Text] [Related]
5. Preclinical Evaluation of a Novel Small Molecule LCC-21 to Suppress colorectal cancer Malignancy by Inhibiting Angiogenic and Metastatic Signatures.
Mokgautsi N; Kuo YC; Huang YJ; Chen CH; Mukhopadhyay D; Wu ATH; Huang HS
Cells; 2023 Jan; 12(2):. PubMed ID: 36672201
[TBL] [Abstract] [Full Text] [Related]
6. Upregulation of miR-22-3p contributes to plumbagin-mediated inhibition of Wnt signaling in human colorectal cancer cells.
Yadav P; Sharma P; Chetlangia N; Mayalagu P; Karunagaran D
Chem Biol Interact; 2022 Dec; 368():110224. PubMed ID: 36272469
[TBL] [Abstract] [Full Text] [Related]
7. Blockage of Wnt/β-catenin Signaling Pathway in colorectal cancer Resistant Cells by Nitazoxanide Effects on Peptidylarginine Deiminases Expression.
Hemmati-Dinarvand M; Kheirandish S; Khodadadian A; Mostafazadeh M; Seghatoleslam A
Asian Pac J Cancer Prev; 2022 Sep; 23(9):3215-3222. PubMed ID: 36172687
[TBL] [Abstract] [Full Text] [Related]
8. Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies.
Powell CA; Modi S; Iwata H; Takahashi S; Smit EF; Siena S; Chang DY; Macpherson E; Qin A; Singh J; Taitt C; Shire N; Camidge DR
ESMO Open; 2022 Aug; 7(4):100554. PubMed ID: 35963179
[TBL] [Abstract] [Full Text] [Related]
9. The Role of Pharmacotherapeutic Agents in Children with Desmoid Tumors.
Douglass DP; Navid F; Weiss AR
Paediatr Drugs; 2022 Sep; 24(5):433-445. PubMed ID: 35902507
[TBL] [Abstract] [Full Text] [Related]
10. circIFT80 Functions as a ceRNA for miR-142, miR-568, and miR-634 and Promotes the Progression of colorectal cancer by Targeting
Liu N; Jiang F; Chen Z; Liu X; Zhiming FU; Wang BC; Lv Y
Dis Markers; 2022; 2022():8081246. PubMed ID: 35783013
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive genetic characterization of rectal cancer in a large cohort of Japanese patients: differences according to tumor location.
Hino H; Shiomi A; Hatakeyama K; Kagawa H; Manabe S; Yamaoka Y; Nagashima T; Ohshima K; Urakami K; Akiyama Y; Yamaguchi K
J Gastroenterol; 2022 Jul; 57(7):476-485. PubMed ID: 35449312
[TBL] [Abstract] [Full Text] [Related]
12. Allele-specific endogenous tagging and quantitative analysis of β-catenin in colorectal cancer cells.
Ambrosi G; Voloshanenko O; Eckert AF; Kranz D; Nienhaus GU; Boutros M
Elife; 2022 Jan; 11():. PubMed ID: 35014953
[TBL] [Abstract] [Full Text] [Related]
13. Circulating tumor DNA-based early detection of precancerous colorectal lesions using QClamp XNA-mediated real-time PCR.
Chen S; Wang Y; Wang K; Zhang L; Zhang X
Pharmazie; 2021 Dec; 76(12):606-610. PubMed ID: 34986957
[TBL] [Abstract] [Full Text] [Related]
14. Nitazoxanide and cancer Drug Resistance: Targeting Wnt/β-catenin Signaling Pathway.
Hemmati-Dinarvand M; Ahmadvand H; Seghatoleslam A
Arch Med Res; 2022 Apr; 53(3):263-270. PubMed ID: 34937659
[TBL] [Abstract] [Full Text] [Related]
15. C644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth.
Yan Y; Zhang Y; Li M; Zhang Y; Zhang X; Zhang X; Xu Y; Wei W; Wang J; Xu X; Song Q; Zhao C
Cancer Sci; 2021 Nov; 112(11):4722-4735. PubMed ID: 34431598
[TBL] [Abstract] [Full Text] [Related]
16. Identification of m6A-Related Biomarkers Associated with Prognosis of colorectal cancer.
Zhang Z; Zhang X
Med Sci Monit; 2021 Aug; 27():e932370. PubMed ID: 34373442
[TBL] [Abstract] [Full Text] [Related]
17. Mathematical modeling of multiple pathways in colorectal carcinogenesis using dynamical systems with Kronecker structure.
Haupt S; Zeilmann A; Ahadova A; Bläker H; von Knebel Doeberitz M; Kloor M; Heuveline V
PLoS Comput Biol; 2021 May; 17(5):e1008970. PubMed ID: 34003820
[TBL] [Abstract] [Full Text] [Related]
18. A modified protein marker panel to identify four consensus molecular subtypes in colorectal cancer using immunohistochemistry.
Li X; Larsson P; Ljuslinder I; Ling A; Löfgren-Burström A; Zingmark C; Edin S; Palmqvist R
Pathol Res Pract; 2021 Apr; 220():153379. PubMed ID: 33721619
[TBL] [Abstract] [Full Text] [Related]
19. Clinical application of next-generation sequencing for the management of desmoid tumors: A case report and literature review.
Lee JM; Kim HG; Shin SY; Lee SH
Medicine (Baltimore); 2021 Jan; 100(1):e24238. PubMed ID: 33429825
[TBL] [Abstract] [Full Text] [Related]
20. Piperine suppresses the Wnt/β-catenin pathway and has anti-cancer effects on colorectal cancer cells.
de Almeida GC; Oliveira LFS; Predes D; Fokoue HH; Kuster RM; Oliveira FL; Mendes FA; Abreu JG
Sci Rep; 2020 Jul; 10(1):11681. PubMed ID: 32669593
[TBL] [Abstract] [Full Text] [Related]
[Next]
